Jose Ignacio Martin-Subero
Overview
Explore the profile of Jose Ignacio Martin-Subero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
2053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Abdelrazak Morsy M, Lilienthal I, Lord M, Merrien M, Wasik A, Sureda-Gomez M, et al.
Blood
. 2024 Jan;
143(19):1953-1964.
PMID: 38237141
Sterile alpha motif and histidine-aspartate (HD) domain-containing protein 1 (SAMHD1) is a deoxynucleoside triphosphate triphosphohydrolase with ara-CTPase activity that confers cytarabine (ara-C) resistance in several hematological malignancies. Targeting SAMHD1's ara-CTPase...
12.
Maiques-Diaz A, Martin-Subero J
Semin Hematol
. 2023 Dec;
61(3):172-180.
PMID: 38151379
Chronic lymphocytic leukemia (CLL) is characterized by widespread alterations in the genetic and epigenetic landscapes which seem to underlie the variable clinical manifestations observed in patients. Over the last decade,...
13.
Grau M, Lopez C, Martin-Subero J, Bea S
Best Pract Res Clin Haematol
. 2023 Dec;
36(4):101513.
PMID: 38092483
For the routine diagnosis of haematological neoplasms an integrative approach is used considering the morphology, and the immunophenotypic, and molecular features of the tumor sample, along with clinical information. The...
14.
Ramsower C, Rosenthal A, Robetorye R, Mwangi R, Maurer M, Villa D, et al.
Br J Haematol
. 2023 Oct;
204(1):160-170.
PMID: 37881141
Mantle cell lymphoma (MCL) is clinically and biologically heterogeneous. While various prognostic features have been proposed, none currently impact therapy selection, particularly in older patients, for whom treatment is primarily...
15.
Duran-Ferrer M, Martin-Subero J
Annu Rev Pathol
. 2023 Oct;
19:371-396.
PMID: 37832942
Lymphoid neoplasms represent a heterogeneous group of disease entities and subtypes with markedly different molecular and clinical features. Beyond genetic alterations, lymphoid tumors also show widespread epigenomic changes. These severely...
16.
Fernandez-Garnacho E, Nadeu F, Martin S, Mozas P, Rivero A, Delgado J, et al.
Sci Rep
. 2023 Oct;
13(1):16839.
PMID: 37803049
MALAT1 long non-coding RNA has oncogenic roles but has been poorly studied in indolent B-cell neoplasms. Here, MALAT1 expression was analyzed using RNA-seq, microarrays or qRT-PCR in primary samples from...
17.
De Rop F, Hulselmans G, Flerin C, Soler-Vila P, Rafels A, Christiaens V, et al.
Nat Biotechnol
. 2023 Aug;
42(6):916-926.
PMID: 37537502
Single-cell assay for transposase-accessible chromatin by sequencing (scATAC-seq) has emerged as a powerful tool for dissecting regulatory landscapes and cellular heterogeneity. However, an exploration of systemic biases among scATAC-seq technologies...
18.
Tsagiopoulou M, Chapaprieta V, Russinol N, Garcia-Torre B, Pechlivanis N, Nadeu F, et al.
Blood
. 2023 Mar;
141(24):2955-2960.
PMID: 36989492
The chromatin activation landscape of chronic lymphocytic leukemia (CLL) with stereotyped B-cell receptor immunoglobulin is currently unknown. In this study, we report the results of a whole-genome chromatin profiling of...
19.
Vila-Pueyo M, Cuenca-Leon E, Queiros A, Kulis M, Sintas C, Cormand B, et al.
Cephalalgia
. 2023 Feb;
43(2):3331024221146317.
PMID: 36759321
Background: Cortical spreading depolarization, the cause of migraine aura, is a short-lasting depolarization wave that moves across the brain cortex, transiently suppressing neuronal activity. Prophylactic treatments for migraine, such as...
20.
Broseus J, Hergalant S, Vogt J, Tausch E, Kreuz M, Mottok A, et al.
Nat Commun
. 2023 Jan;
14(1):309.
PMID: 36658118
Richter syndrome (RS) is the transformation of chronic lymphocytic leukemia (CLL) into aggressive lymphoma, most commonly diffuse large B-cell lymphoma (DLBCL). We characterize 58 primary human RS samples by genome-wide...